| 2026 | | Establishing an Active Vaccine Safety Surveillance System Using Large Scale Databases in Korea: Lessons and Scalable Insights for Global Application
Journal of Korean medical science, 41(1). : e47-e47, 2026 | 허중연, 현학준 |
| 2025 | | Optimizing Vancomycin Area under the Concentration-Time Curve Targets in Enterococcal Bacteremia: Balancing Efficacy and Nephrotoxicity
Yonsei medical journal, 66(9). : 609-617, 2025 | 김영롱, 김은진, 최영화, 허중연, 현학준 |
| 2025 | | Sentinel Safety Monitoring System for Adverse Events of Special Interest Associated With Non-NIP Vaccines in Korea
Journal of Korean medical science, 40(16). : e152-e152, 2025 | 허중연, 현학준 |
| 2025 | | Corrigendum to The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: propensity score-matched analysis with influenza vaccination
Vaccine, 46. : 126676-126676, 2025 | 현학준 |
| 2025 | | The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination
Vaccine, 44. : 126506-126506, 2025 | 현학준 |
| 2024 | | Effectiveness of quadrivalent meningococcal conjugate vaccine against meningococcal carriage and genotype character changes: A secondary analysis of prospective cohort study in Korean military trainees
International journal of infectious diseases, 146. : 107150-107150, 2024 | 김영롱, 김은진, 유진세, 최영화, 허중연, 현학준 |
| 2024 | | Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination
Frontiers in immunology, 15. : 1385135-1385135, 2024 | 현학준 |
| 2024 | | Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach
Clinical microbiology and infection, 30(5). : 646-652, 2024 | 현학준 |
| 2024 | | Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy
Heliyon, 10(5). : e27211-e27211, 2024 | 허중연, 현학준 |
| 2023 | | Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations
Vaccines, 11(8). : 1320-1320, 2023 | 현학준 |
